Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Effects of glutamate modulation on anxiety symptoms


To see complete record on anzctr.org.au, please visit this link

Id: ACTRN12615000617561

Organisation Name: University of Otago

Overal Status: Completed

Start Date: 03/08/2015

Brief Summary: The glutamate antagonist ketamine has rapid onset antidepressant effects in patients with treatment-resistant depression. Patients with OCD and PTSD have had similarly rapid improvement in symptoms when administered ketamine. This study will assess if similar improvements occur in patients with GAD and SP.

Countries:
  • New Zealand


Total execution time in seconds: 0.17203402519226